Skip to main content
SpringerLink
Log in

What’s New About the New US Obesity Guidelines?

  • Invited Commentary
  • Published:
Current Obesity Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Hoerger T. Controversies in obesity mortality: a tale of two studies. RTI-UNC Center of Excellence in Health Promotion Economics. 2006;1:1–5.

  2. TOS Obesity as a Disease Writing Group: David B. Allison(chair)1, Morgan Downey (co-chair) Richard L. Atkinson, Charles J. Billington, George A. Bray, Robert H. Eckel, Eric A. Finkelstein, Michael D. Jensen and Angelo Tremblay. Obesity as a disease: a white paper on evidence and arguments commissioned by the Council of the Obesity Society. Obesity. 2008. doi:10.1038/oby.2008.231.

  3. Jensen MD, Ryan DH, Donato KA, Apovian CM, Ard JD, Comuzzie AG, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Obesity. 2013. doi:10.1002/oby.20660.

    PubMed Central  Google Scholar 

  4. Expert Panel on the Identification, Evaluation, and Treatment of Obesity in Adults. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Obes Res. 1998;6(6):464.

    Article  Google Scholar 

  5. Jensen MD, Ryan DH. New obesity guidelines: promise and potential. JAMA. 2014;311(1):23–4. doi:10.1001/jama.2013.282546.

    Article  PubMed  CAS  Google Scholar 

  6. Donnelly JE, Blair SN, Jakicic JM, Manore MM, Rankin JW, Smith BK, et al. American College of Sports Medicine Position Stand. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults. Med Sci Sports Exerc. 2009;41(2):459–71.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

Caroline M. Apovian has received grant support from National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK073302, P30 DK046200, R01 DK080448, R01 AG037547, R24 DK094749, P01 HL081587).

Compliance with Ethics Guidelines

ᅟ

Conflict of Interest

Caroline M. Apovian reports personal fees for participating on Advisory Boards from Allergan, Inc., Orexigen Therapeutics, Johnson & Johnson Services, Inc., Merck & Co., Inc., Abbott Nutrition, Arena Pharmaceuticals, Amylin Pharmaceuticals, Novo Nordisk, Inc., NutriSystem, Inc., Sanofi-Aventis US, LLC, GI Dynamics, Inc., and Zafgen, grants from MetaProteomics, LLC, The Dr. Robert C. and Veronica Atkins Foundation, Sanofi-Aventis US, LLC, Pfizer, Inc., Aspire Bariatrics, Inc., GI Dynamics, Inc., Amylin Pharmaceuticals, and Orexigen Therapeutics, outside the submitted work.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. Boston University School of Medicine, Boston, MA, USA

    Caroline M. Apovian

  2. Section for Endocrinology, Diabetes and Nutrition, Boston Medical Center, 88 East Newton Street, Robinson Bldg, Suite 4400, Boston, MA, USA

    Caroline M. Apovian

Authors
  1. Caroline M. Apovian
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Caroline M. Apovian.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Apovian, C.M. What’s New About the New US Obesity Guidelines?. Curr Obes Rep 3, 147–149 (2014). https://doi.org/10.1007/s13679-014-0103-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13679-014-0103-1

Keywords

Search

Navigation